Friel Robert F
SEC-identified person · CIK 1224110 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Xylem Inc. XYL | Director | filed 2012–2026 |
| West Pharmaceutical Services INC wst | Director | filed 2020–2026 |
| Nuvasive INC NUVA | Director | filed 2016–2023 |
| Revvity, INC. RVTY | Director · Vice Chairman; President & COO | filed 2006–2019 |
| Carefusion Corp CFN | Director | filed 2009–2015 |
| Fairchild Semiconductor International INC FCS | Director | filed 2006–2009 |
| Millennium Pharmaceuticals INC MLNM | Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.